Variants in nucleocapsid protein and endoRNase are found to associate with severe COVID-19 in a case-control study in Washington State, USA

Lue Ping Zhao, Pavitra Roychoudhury, Keith R. Jerome, Peter B. Gilbert, Joshua T. Schiffer, Terry P. Lybrand, Thomas H. Payne, April K. Randhawa, Sara E Thiebaud, Margaret G. Mills, Alexander L. Greninger, Chu-Woo Pyo, Ruihan Wang, Renyu Li, Alexander Thomas, Brandon Norris, Wyatt C. Nelson, Daniel E. GeraghtyResearch 2021 · DOI

Introduction

While genomic surveillance of SARS-CoV-2 has predominantly focused on the Spike protein due to its role in viral entry and vaccine evasion, the genetic determinants of disease severity (virulence) remain less understood. Transmissibility is only one aspect of the pandemic; understanding why some variants cause mild symptoms while others lead to respiratory failure is critical for clinical management. This study investigates the association between specific viral variants and clinical outcomes, identifying a significant genetic signature outside the Spike protein that is linked to a high risk of hospitalization.

Methods

Researchers employed a robust two-stage case-control design to identify variants associated with virulence. The Discovery Phase analyzed 683 patients in Washington State (388 inpatients and 295 outpatients) from April to August 2020. To filter out stochastic "noise," the team cross-referenced findings with 7,137 viral sequences from the GISAID database, focusing on Single Nucleotide Variants (SNVs) that showed significant population expansion.

Statistical associations were modeled using Generalized Additive Models (GAMs) to account for the dynamic expansion of variants over time. This allowed the researchers to distinguish between transient variants and those becoming dominant in the population. The findings were then validated in an Independent Replication Cohort of 964 patients collected between June 2020 and March 2021.

Key Findings: The "caac" Haplotype

The analysis identified a four-SNV haplotype, termed "caac," which travels in near-perfect linkage disequilibrium. This haplotype consists of:

  • One synonymous mutation in the endoRNase gene (t19839).
  • Three non-synonymous mutations in the nucleocapsid (N) protein (g28881, g28882, and g28883).

This haplotype demonstrated a powerful association with severe disease, with an Odds Ratio (OR) of 5.46 ($p = 4.71 \times 10^{-12}$) in the replication cohort. Interestingly, the common Spike protein mutation D614G showed no significant correlation with hospitalization in this study, suggesting that virulence factors may be independent of transmissibility factors.

Mechanistic Hypotheses

The three mutations in the N-protein (R203K, R203S, and G204R) are located within a "flexible linker region." The authors hypothesize that these changes alter the protein's flexibility and host RNA binding dynamics, potentially hyper-activating the immune response. Such alterations could contribute to the "cytokine storms" characteristic of severe COVID-19.

Furthermore, while the endoRNase mutation (N73N) is synonymous (meaning it does not change the amino acid), it may still impact the virus by affecting protein folding speed or translation kinetics, providing a subtle but significant fitness advantage.

Conclusion and Future Directions

The study highlights a critical need to expand genomic surveillance beyond the Spike protein. The "caac" haplotype, predominantly found in the B.1.1.291 lineage, serves as a specific target for future tracking. These results emphasize the importance of linking viral genomic sequences with Electronic Health Records (EHR) to enable real-time identification of high-consequence variants. While the statistical association is strong, the authors call for functional "wet-lab" studies to confirm the exact molecular mechanisms by which these N-protein mutations trigger severe physiological responses.

Summary updated

Abstract

Abstract SARS-CoV-2 is spreading worldwide with continuously evolving variants, some of which occur in the Spike protein and appear to increase the viral transmissibility. However, variants that cause severe COVID-19 or lead to other breakthroughs have not been well characterized. To discover such viral variants, we assembled a cohort of 683 COVID-19 patients; 388 inpatients (“cases”) and 295 outpatients (“controls”) from April to August 2020 using electronically captured COVID test request forms and sequenced their viral genomes. To improve the analytic power, we accessed 7,137 viral sequences in Washington State to filter out viral single nucleotide variants (SNVs) that did not have significant expansions over the collection period. Applying this filter led to the identification of 53 SNVs that were statistically significant, of which 13 SNVs each had 3 or more variant copies in the discovery cohort. Correlating these selected SNVs with case/control status, eight SNVs were found to significantly associate with inpatient status (q-values<0.01). Using temporal synchrony, we identified a four SNV-haplotype (t19839-g28881-g28882-g28883) which was significantly associated with case/control status (Fisher’s exact p=2.84*10-11) that appeared in April 2020, peaked in June, and persisted into January 2021. This association was replicated (OR=5.46, p-value=4.71*10-12) in an independent cohort of 964 COVID-19 patients (June 1, 2020 to March 31, 2021). The haplotype included a synonymous change N73N in endoRNase, and three non-synonymous changes coding residues R203K, R203S and G204R in the nucleocapsid protein. This discovery points to the potential functional role of the nucleocapsid protein in triggering “cytokine storms” and severe COVID-19 that led to hospitalization. The study further emphasizes a need for tracking and analyzing viral sequences in correlations with clinical status.
BibTeX
@inproceedings{zhao2021variants,
  author = {Lue Ping Zhao and Pavitra Roychoudhury and Keith R. Jerome and Peter B. Gilbert and Joshua T. Schiffer and Terry P. Lybrand and Thomas H. Payne and April K. Randhawa and Sara E Thiebaud and Margaret G. Mills and Alexander L. Greninger and Chu-Woo Pyo and Ruihan Wang and Renyu Li and Alexander Thomas and Brandon Norris and Wyatt C. Nelson and Daniel E. Geraghty},
  title = {{Variants in nucleocapsid protein and endoRNase are found to associate with severe COVID-19 in a case-control study in Washington State, USA}},
  booktitle = {Research},
  year = {2021},
  doi = {10.21203/rs.3.rs-888049/v1},
}
Figure